REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
14,303,307
Share change
-7,837,997
Total reported value
$7,295,026
Price per share
$0.51
Number of holders
29
Value change
+$761,427
Number of buys
17
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q1 2017

As of 31 Mar 2017, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,303,307 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., NORTHERN TRUST CORP, HUDSON VALLEY INVESTMENT ADVISORS INC /ADV, ACADIAN ASSET MANAGEMENT LLC, Northeast Financial Consultants Inc, Bank of New York Mellon Corp, and Benin Management CORP. This page lists 29 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.